Purpose of the Test
- Early detection of bladder tumors in high-risk individuals.
- Monitoring patients post-surgery to detect early recurrence.
- Evaluating cases of unexplained hematuria (blood in urine).
Book NMP22 Bladder Cancer Test | Lahalak Medical Platform
The NMP22 urine marker test provides a non-invasive, highly accurate diagnostic tool for early bladder cancer detection and monitoring, ensuring timely medical intervention and improved patient outcomes for high-risk individuals.
Scientific name: Nuclear Matrix Protein 22 (NMP22) Urine Test
A laboratory test measuring NMP22 protein levels in urine. It aids in diagnosing bladder cancer and monitoring recurrence post-surgery, providing a reliable diagnostic marker alongside clinical evaluations.
Service type
Laboratory test
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Urine sample collection
- Quantitative NMP22 measurement
- Laboratory results report
Medical Service Information
Target Groups
- Long-term current and former smokers.
- Workers exposed to industrial chemicals and dyes.
- Individuals with a family history of bladder malignancies.
Test Benefits
- Non-invasive and easy procedure.
- High sensitivity for tumor-associated proteins.
- Convenient home collection service available.
Conditions & Notices
- Early morning sample collection is preferred
- Inform the lab of any current urinary infections
Medical services you might also like
